Access cutting-edge participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study treatment through this clinical trial at a research site in Culver City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Culver City location
Preparing your pre-screening questions…
Access participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study treatment provided free
Check if you qualify for this participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study clinical trial in Culver City, CA
No-Cost Study Care
Local to Culver City
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to collect information on the long-term safety of study participants who received an Allogeneic Chimeric Antigen Receptor (CAR) T-Cell Product in an Imugene Clinical Study. The main questions it aims to answer are: * What are the frequency, severity, duration, and outcome of clinically significant Clinical Events of Interest (CEI)? * What is the duration of response and overall survival time after taking an allogeneic CAR T-Cell product on an Imugene clinical study? Participants will have a yearly visit either face to face or remotely for up to 15 years to check for CEI.
Sponsor: Imugene Limited
Yes, this clinical trial (NCT05822427) has an active research site in Culver City, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study treatment options in Culver City, CA, this clinical trial (NCT05822427) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Culver City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Culver City — not just this study.
Browse Leukemia Trials in Culver City →